Closys Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

SENSODYNE PRONAMEL is the best-performing closys brand in July 2026, moving 60,000 units across 2 ASINs for 35.9% of Top 10 volume. TheraBreath follows with 50,000 units (29.9%), ahead of CloSYS on 47,000 units (28.1%).

With 4 brands splitting the Top 10 and 94.0% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $16.97 to $22.12, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B0758F8KDC leads positive momentum with ▲ 400.0% MoM growth on 50K units, with B0G7FHVZL3 close behind at ▲ 200.0% MoM on 600 units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.